Alnylam Pharmaceuticals, Inc. (ALNY)

398.29 -1.11 (-0.28%) USD  |  NASDAQ  |  Jan 09, 16:00
389.40 -8.89 (-2.23%) After-Hours: 05:58
More

Alnylam Pharmaceuticals Operating Income (TTM)

Operating Income (TTM) Chart

View Operating Income (TTM) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (TTM) Range, Past 5 Years

View Operating Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (TTM) Benchmarks

View Operating Income (TTM) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Pfizer Inc. Upgrade
Biogen, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
BridgeBio Pharma, Inc. Upgrade